Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Romy Tilen"'
Autor:
Patrick M. Meyer Sauteur, Michelle Seiler, Romy Tilen, Ester Osuna, Margarete von Wantoch, Semjon Sidorov, Christoph Aebi, Philipp Agyeman, Florence Barbey, Julia A. Bielicki, Ludivine Coulon, Beate Deubzer, Alex Donas, Ulrich Heininger, Kristina Keitel, Henrik Köhler, Lisa Kottanattu, Roger Lauener, Anita Niederer-Loher, Klara M. Posfay-Barbe, Maren Tomaske, Noémie Wagner, Petra Zimmermann, Franziska Zucol, Stefanie von Felten, Christoph Berger
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-20 (2024)
Abstract Background Mycoplasma pneumoniae is a major cause of community-acquired pneumonia (CAP) in school-aged children. Macrolides are the first-line treatment for this infection. However, it is unclear whether macrolides are effective in treating
Externí odkaz:
https://doaj.org/article/eb0e92befef446dbb3aa3b6815762a10
Autor:
Elisabeth V. Giger, Romy Tilen
Publikováno v:
Children, Vol 10, Iss 11, p 1802 (2023)
We read the article by Shaniv D. et al. entitled “Neonatal Drug Formularies—A Global Scope” [...]
Externí odkaz:
https://doaj.org/article/5113d9e87e5443429779a538904bf6a4
Autor:
Roland Goers, Diana Coman Schmid, Vera F. Jäggi, Paolo Paioni, Michal J. Okoniewski, Althea Parker, Beat Bangerter, Sofia Georgakopoulou, Thierry Sengstag, Julia Bielicki, Romy Tilen, Swen Vermeul, Stefanie D. Krämer, Christoph Berger, Bernd Rinn, Henriette E. Meyer zu Schwabedissen
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 12, Pp 1578-1587 (2021)
Abstract Clinical trials have been performed mainly in adults and accordingly the necessary information is lacking for pediatric patients, especially regarding dosage recommendation for approved drugs. This gap in information could be filled with res
Externí odkaz:
https://doaj.org/article/1bfbcff86d324ff3b15781ea26768d4d
Autor:
Romy Tilen, Paolo Paioni, Aljoscha N. Goetschi, Roland Goers, Isabell Seibert, Daniel Müller, Julia A. Bielicki, Christoph Berger, Stefanie D. Krämer, Henriette E. Meyer zu Schwabedissen
Publikováno v:
Pharmaceutics, Vol 14, Iss 6, p 1289 (2022)
Voriconazole is among the first-line antifungal drugs to treat invasive fungal infections in children and known for its pronounced inter- and intraindividual pharmacokinetic variability. Polymorphisms in genes involved in the metabolism and transport
Externí odkaz:
https://doaj.org/article/1063935f041f4117ae1ad62a4e36bbe6
Autor:
Paolo Paioni, Vera F. Jäggi, Romy Tilen, Michelle Seiler, Philipp Baumann, Dominic S. Bräm, Carole Jetzer, Robin T. U. Haid, Aljoscha N. Goetschi, Roland Goers, Daniel Müller, Diana Coman Schmid, Henriette E. Meyer zu Schwabedissen, Bernd Rinn, Christoph Berger, Stefanie D. Krämer
Publikováno v:
Pharmaceutics, Vol 13, Iss 10, p 1596 (2021)
The aminoglycoside gentamicin is used for the empirical treatment of pediatric infections. It has a narrow therapeutic window. In this prospective study at University Children’s Hospital Zurich, Switzerland, we aimed to characterize the pharmacokin
Externí odkaz:
https://doaj.org/article/acfd0ccad93d4489bfdb8b56e9eb95a5
Autor:
Romy Tilen, Christoph Berger
Publikováno v:
Schweizerische Ärztezeitung.
Autor:
Romy Tilen, Christoph Berger
Publikováno v:
Bulletin des Médecins Suisses.
Autor:
Christoph Berger, Thomas Sabine, Samuel Aeschbacher, Romy Tilen, Dalibor Panis, Henriette E. Meyer zu Schwabedissen
Publikováno v:
European Journal of Pediatrics. 181:1221-1231
In daily paediatrics, drugs are commonly used off-label, as they are not approved for children. Approval is lacking because the required clinical studies were limited to adults in the past. Without clinical studies, evidence-based recommendations for
Autor:
Romy Tilen, Bernd Rinn, Michal J. Okoniewski, Stefanie D. Krämer, Diana Coman Schmid, Henriette E. Meyer zu Schwabedissen, Swen Vermeul, Sofia Georgakopoulou, Christoph Berger, Roland Goers, Beat Bangerter, Julia Bielicki, Thierry Sengstag, Vera F. Jäggi, Paolo Paioni, Althea Parker
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 12, Pp 1578-1587 (2021)
Clinical trials have been performed mainly in adults and accordingly the necessary information is lacking for pediatric patients, especially regarding dosage recommendation for approved drugs. This gap in information could be filled with results from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::921eee4f9c281ca95942a4a34c61e292
https://openaccess.sgul.ac.uk/id/eprint/113864/1/psp4.12723.pdf
https://openaccess.sgul.ac.uk/id/eprint/113864/1/psp4.12723.pdf
Autor:
Roland, Goers, Diana, Coman Schmid, Vera F, Jäggi, Paolo, Paioni, Michal J, Okoniewski, Althea, Parker, Beat, Bangerter, Sofia, Georgakopoulou, Thierry, Sengstag, Julia, Bielicki, Romy, Tilen, Swen, Vermeul, Stefanie D, Krämer, Christoph, Berger, Bernd, Rinn, Henriette E, Meyer Zu Schwabedissen
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
Clinical trials have been performed mainly in adults and accordingly the necessary information is lacking for pediatric patients, especially regarding dosage recommendation for approved drugs. This gap in information could be filled with results from